Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis
ClinicalTrials.gov study NCT05919082. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
ClinicalTrials.gov study NCT01708629. IPD Sharing: YES. Countries: 11. Publications: 6.
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
ClinicalTrials.gov study NCT04533737. IPD Sharing: NO. Countries: 12. Publications: 1.
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
ClinicalTrials.gov study NCT03535194. IPD Sharing: YES. Countries: 16. Publications: 1.
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
ClinicalTrials.gov study NCT06220604. IPD Sharing: YES. Countries: 11. Publications: 1.
Study to Assess the Efficacy and Safety of Orismilast in Psoriasis
ClinicalTrials.gov study NCT05190419. IPD Sharing: NO. Countries: 4. Publications: 1.
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)
ClinicalTrials.gov study NCT02742441. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy and Safety of TC Cream In Treating Patients With Psoriasis Vulgaris
ClinicalTrials.gov study NCT03372811. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00307437. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
ClinicalTrials.gov study NCT02317627. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris
ClinicalTrials.gov study NCT03073213. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis
ClinicalTrials.gov study NCT03624127. IPD Sharing: Not stated. Countries: 11. Publications: 7.
Topical CP-690,550 For Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00678561. IPD Sharing: YES. Countries: 2. Publications: 1.
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
ClinicalTrials.gov study NCT05028582. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT06143878. IPD Sharing: YES. Countries: 13. Publications: 1.
Tofacitinib Ointment For Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01831466. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
ClinicalTrials.gov study NCT00688519. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT04607980. IPD Sharing: YES. Countries: 8. Publications: 1.
Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
ClinicalTrials.gov study NCT01999868. IPD Sharing: Not stated. Countries: 2. Publications: 1.
First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks
ClinicalTrials.gov study NCT01555125. IPD Sharing: Not stated. Countries: 5. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.